Narayanan Gopalakrishna Iyer

Title: Narayanan Gopalakrishna Iyer: Innovator in Antibody Research

Introduction

Narayanan Gopalakrishna Iyer is a prominent inventor based in Singapore, known for his significant contributions to the field of antibody research. He holds a total of 6 patents, showcasing his innovative approach to medical science and cancer treatment.

Latest Patents

One of his latest patents is focused on Anti-CEACAM6 antibodies and methods of use. This invention relates to an antigen-binding protein, or an antigen-binding fragment thereof, which binds to CEACAM6. The heavy chain variable domain comprises specific amino acid sequences, including VHCDR1, VHCDR2, and VHCDR3. Additionally, the light chain variable domain includes VLCDR1, VLCDR2, and VLCDR3. The invention also encompasses compositions that include the antigen-binding protein, methods for its use in cancer treatment, prevention, or detection, and a kit containing the antigen-binding protein or its fragment.

Career Highlights

Narayanan has worked with notable organizations such as Singapore Health Services Pte Ltd and the Agency for Science, Technology and Research. His work in these institutions has contributed to advancements in healthcare and research.

Collaborations

He has collaborated with esteemed colleagues, including Hau Wan Leung and Andre Boon Hwa Choo, further enhancing the impact of his research and innovations.

Conclusion

Narayanan Gopalakrishna Iyer's work in antibody research exemplifies the spirit of innovation in the medical field. His contributions are paving the way for new treatments and methods in cancer care.